www.fdanews.com/articles/149006-fda-provides-recommendations-for-phase-ii-protocol-for-low-dose-oral-proellex-in-the-treatment-of-endometriosis
FDA Provides Recommendations for Phase II Protocol for Low Dose Oral Proellex in the Treatment of Endometriosis
August 28, 2012
Repros Therapeutics Inc. announced the FDA has provided guidance for a Phase II study of low dose oral Proellex in the treatment of endometriosis.
Seeking Alpha
Seeking Alpha